Stock Detail
DUSA PHARMACEUTICALS INC
Drug Manufacturers Other
DUSA @ Yahoo Finance | DUSA Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $3.50 | $3.60 | $-0.03 | -0.85% | 0.00 | $3.53 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $3.50 | $3.45 | 88,701 | 86.27M | 154,759.33 | 13.32 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 3.67 | 3.59 | 3.52 | 3.44 | 3.37 |
Stock Profile
DUSA Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and marketing of a drug named 5-aminolevulinic acid (ALA). ALA is used in combination with appropriate light devices in order to detect or treat a variety of medical conditions, such as photodynamic therapy or photodetection. Its products include Levulan 20% topical solution using its Kerastick brand applicator, and BLU-U brand light unit for the treatment of actinic keratoses (AKs). AKs are precancerous skin lesions caused by chronic sun exposure that can develop over time into a form of skin cancer called squamous cell carcinoma. The company's products are used together to provide photodynamic therapy for the treatment of nonhyperkeratotic actinic keratoses of the face or scalp. Kerastick is a single-use, disposable applicator, which allows for the rapid preparation and uniform application of Levulan topical solution in standardized doses. In addition, the BLU-U is used without Levulan for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions. The company offers its products through direct and third party distributors in the United States. DUSA Pharmaceuticals was incorporated in 1991 and is headquartered in Wilmington, Massachusetts.